Overview

A Multicenter, Therapeutic Used Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial Disease

Status:
Unknown status
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate symptomatic changes and safety before and after the administration of Pletaal® SR Capsules based on Peripheral Artery Questionnaire (PAQ) in subjects with peripheral arterial disease symptom due to chronic occlusive arterial disease (COAD).
Phase:
Phase 4
Details
Lead Sponsor:
Korea Otsuka Pharmaceutical Co., Ltd.